| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Nathaly Gaudreault, Denis Gravel, Sylvie Nadea. Evaluation of plantar flexion contracture contribution during the gait of children with Duchenne muscular dystrophy. Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology. vol 19. issue 3. 2009-06-02. PMID:17977021. |
we believe that the passive moments can compensate for the presence of progressive muscle weakness in the children with dmd and help these children with gait. |
2009-06-02 |
2023-08-12 |
human |
| Myriam Srour, Bassam A Bejjani, Emily A Rorem, Nicholas Hall, Lisa G Shaffer, Michael I Shevel. An instructive case of an 8-year-old boy with intellectual disability. Seminars in pediatric neurology. vol 15. issue 4. 2009-02-19. PMID:19073314. |
given the familial and therapeutic implications for accurate diagnosis of dmd mutations, this case raises the possible need for screening boys with global developmental delay/intellectual disability even in the absence of any overt muscle weakness and further shows the utility of comparative genomic hybridization (cgh) analysis in the evaluation of patients with nonsyndromic mental retardation. |
2009-02-19 |
2023-08-12 |
Not clear |
| Alexandre Briguet, Michael Erb, Isabelle Courdier-Fruh, Patrizia Barzaghi, Gesa Santos, Holger Herzner, Cyrille Lescop, Hervé Siendt, Marco Henneboehle, Philipp Weyermann, Josef P Magyar, Judith Dubach-Powell, Günther Metz, Thomas Meie. Effect of calpain and proteasome inhibition on Ca2+-dependent proteolysis and muscle histopathology in the mdx mouse. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 22. issue 12. 2008-12-31. PMID:18728218. |
dystrophin deficiency is the underlying molecular cause of progressive muscle weakness observed in duchenne muscular dystrophy (dmd). |
2008-12-31 |
2023-08-12 |
mouse |
| M Marini, A A Salmi, M S Watihayati, M D SMardziah, M K Zahri, B P Hoh, R Ankathil, P S Lai, B A Zilfali. Screening of dystrophin gene deletions in Malaysian patients with Duchenne muscular dystrophy. The Medical journal of Malaysia. vol 63. issue 1. 2008-11-26. PMID:18935728. |
duchenne muscular dystrophy (dmd) is an x-linked recessive genetic disorder characterized by rapidly progressive muscle weakness. |
2008-11-26 |
2023-08-12 |
Not clear |
| Orvar Eeg-Olofsson, Hannu Kalimo, Karin Edebol Eeg-Olofsson, Sten Jagell, Lena Marklund, Linda Simonsson, Niklas Dah. Duchenne muscular dystrophy and idiopathic hyperCKemia in the same family. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. vol 12. issue 5. 2008-11-06. PMID:18833644. |
a boy showed muscle weakness from the age of 10 months and presented typical signs of dmd at the age of 18 months. |
2008-11-06 |
2023-08-12 |
Not clear |
| Mariz Vainzof, Danielle Ayub-Guerrieri, Paula C G Onofre, Poliana C M Martins, Vanessa F Lopes, Dinorah Zilberztajn, Lucas S Maia, Karen Sell, Lydia U Yamamot. Animal models for genetic neuromuscular diseases. Journal of molecular neuroscience : MN. vol 34. issue 3. 2008-06-20. PMID:18202836. |
the canine golden retriever md model represents a more clinically similar model of dmd due to its larger size and significant muscle weakness. |
2008-06-20 |
2023-08-12 |
mouse |
| M Toussaint, P Soudon, W Kinnea. Effect of non-invasive ventilation on respiratory muscle loading and endurance in patients with Duchenne muscular dystrophy. Thorax. vol 63. issue 5. 2008-05-28. PMID:18057095. |
respiratory muscle weakness in patients with duchenne muscular dystrophy (dmd) leads to respiratory failure for which non-invasive positive pressure ventilation (nippv) is an effective treatment. |
2008-05-28 |
2023-08-12 |
Not clear |
| Denis Duboc, Christophe Meune, Bertrand Pierre, Karim Wahbi, Bruno Eymard, Annick Toutain, Carole Berard, Guy Vaksmann, Simon Weber, Henri-Marc Bécan. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. American heart journal. vol 154. issue 3. 2007-09-05. PMID:17719312. |
duchenne muscular dystrophy (dmd), an x-linked disorder due to lack of dystrophin, is associated with muscle weakness and myocardial dysfunction. |
2007-09-05 |
2023-08-12 |
Not clear |
| Patrick E Baker, Jessica A Kearney, Bendi Gong, Anita P Merriam, Donald E Kuhn, John D Porter, Jill A Rafael-Fortne. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles. Neurogenetics. vol 7. issue 2. 2007-03-27. PMID:16525850. |
dystrophin-deficient mdx mice are characterized by skeletal muscle weakness and degeneration but they appear outwardly normal in contrast to dmd patients. |
2007-03-27 |
2023-08-12 |
mouse |
| Ellen Sterrenburg, Caroline G C van der Wees, Stefan J White, Rolf Turk, Renée X de Menezes, Gert-Jan B van Ommen, Johan T den Dunnen, Peter A C 't Hoe. Gene expression profiling highlights defective myogenesis in DMD patients and a possible role for bone morphogenetic protein 4. Neurobiology of disease. vol 23. issue 1. 2006-09-06. PMID:16679024. |
duchenne muscular dystrophy (dmd) is characterized by progressive muscle weakness and wasting. |
2006-09-06 |
2023-08-12 |
Not clear |
| Marianne Jover, Christina Schmitz, Emmanuelle Bosdure, Brigitte Chabrol, Christine Assaiant. Anticipatory postural adjustments in a bimanual load-lifting task in children with Duchenne muscular dystrophy. Neuroscience letters. vol 403. issue 3. 2006-09-01. PMID:16750880. |
the muscle weakness did not impair (1) the proprioceptive afference and the motor efference constituting the unloading reflex; and (2) the use of an anticipatory function in children with dmd. |
2006-09-01 |
2023-08-12 |
Not clear |
| Jonathan B Strobe. Therapeutics in duchenne muscular dystrophy. NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics. vol 3. issue 2. 2006-05-03. PMID:16554260. |
duchenne muscular dystrophy (dmd) is a fatal disorder affecting approximately 1 in 3,500 live born males, characterized by progressive muscle weakness. |
2006-05-03 |
2023-08-12 |
Not clear |
| Edo M Hoogerwaard, Ieke B Ginjaar, Egbert Bakker, Marianne de Visse. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy. Neurology. vol 65. issue 12. 2006-04-14. PMID:16380627. |
associations between clinical phenotype (muscle weakness, dilated cardiomyopathy) and dystrophin abnormalities in muscle tissue among definite carriers of duchenne (dmd) and becker muscular dystrophy (bmd) were investigated. |
2006-04-14 |
2023-08-12 |
Not clear |
| Leanne M Gauld, Alison Boynton, Grant A Betts, Heather Johnsto. Spirometry is affected by intelligence and behavior in Duchenne muscular dystrophy. Pediatric pulmonology. vol 40. issue 5. 2006-03-16. PMID:16145697. |
children with duchenne muscular dystrophy (dmd) have progressive respiratory muscle weakness. |
2006-03-16 |
2023-08-12 |
Not clear |
| Mitra Lavasani, Aiping Lu, Hairong Peng, James Cummins, Johnny Huar. Nerve growth factor improves the muscle regeneration capacity of muscle stem cells in dystrophic muscle. Human gene therapy. vol 17. issue 2. 2006-03-10. PMID:16454652. |
researchers have attempted to use gene- and cell-based therapies to restore dystrophin and alleviate the muscle weakness that results from duchenne muscular dystrophy (dmd). |
2006-03-10 |
2023-08-12 |
mouse |
| Stéphane Armand, Moïse Mercier, Eric Watelain, Karine Patte, Jacques Pelissier, François Rivie. A comparison of gait in spinal muscular atrophy, type II and Duchenne muscular dystrophy. Gait & posture. vol 21. issue 4. 2005-10-04. PMID:15886126. |
the dmd cases had comparable muscle weakness with the sma ii cases on manual muscle testing and patients were assessed using kinematics, kinetics, electromyography and video analysis. |
2005-10-04 |
2023-08-12 |
Not clear |
| Nicola Laws, Andrew Hoe. Progression of kyphosis in mdx mice. Journal of applied physiology (Bethesda, Md. : 1985). vol 97. issue 5. 2005-02-25. PMID:15234960. |
we hypothesize that paraspinal and respiratory muscle weakness and fibrosis are associated with the progression of spinal deformity in this mouse model, and similar to dmd patients there is evidence of altered thoracic conformation and area. |
2005-02-25 |
2023-08-12 |
mouse |
| David Touboul, Hélène Piednoël, Vincent Voisin, Sabine De La Porte, Alain Brunelle, Frédéric Halgand, Olivier Laprévot. Changes of phospholipid composition within the dystrophic muscle by matrix-assisted laser desorption/ionization mass spectrometry and mass spectrometry imaging. European journal of mass spectrometry (Chichester, England). vol 10. issue 5. 2005-01-04. PMID:15531799. |
duchenne muscular dystrophy (dmd) is a neuromuscular disease linked to the lack of the dystrophin, a submembrane protein, leading to muscle weakness and associated with a defect of the lipid metabolism. |
2005-01-04 |
2023-08-12 |
mouse |
| Akitoshi Miyamoto, Kazumi Taguchi, Soutaro Hieda, Mitsuru Kawamura, Kunihiko Fukuchi, Kunihide Gom. [Detection of micro mutation in dystrophin gene of DMD female carrier]. Rinsho byori. The Japanese journal of clinical pathology. vol 52. issue 6. 2004-08-20. PMID:15283161. |
we attempted to identify a mutation in dystrophin gene in a female patient who was suspected a duchenne muscular dystrophy (dmd) carrier with muscle weakness of upper limbs and congestive heart failure. |
2004-08-20 |
2023-08-12 |
Not clear |
| Johnny Huard, Baohong Cao, Zhuqing Qu-Peterse. Muscle-derived stem cells: potential for muscle regeneration. Birth defects research. Part C, Embryo today : reviews. vol 69. issue 3. 2004-04-30. PMID:14671776. |
duchenne muscular dystrophy (dmd) is a devastating x-linked muscle disease characterized by progressive muscle weakness caused by the lack of dystrophin expression at the sarcolemma of muscle fibers. |
2004-04-30 |
2023-08-12 |
Not clear |